| Product NDC: | 0942-0641 |
| Proprietary Name: | ACD-A |
| Non Proprietary Name: | Anticoagulant Citrate Dextrose Solution Formula A |
| Active Ingredient(s): | 3.65; 12.25; 11 g/500mL; g/500mL; g/500mL & nbsp; Anticoagulant Citrate Dextrose Solution Formula A |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0942-0641 |
| Labeler Name: | Fenwal Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BN160918 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20070301 |
| Package NDC: | 0942-0641-03 |
| Package Description: | 500 mL in 1 BAG (0942-0641-03) |
| NDC Code | 0942-0641-03 |
| Proprietary Name | ACD-A |
| Package Description | 500 mL in 1 BAG (0942-0641-03) |
| Product NDC | 0942-0641 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Anticoagulant Citrate Dextrose Solution Formula A |
| Dosage Form Name | SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20070301 |
| Marketing Category Name | NDA |
| Labeler Name | Fenwal Inc |
| Substance Name | ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM CITRATE |
| Strength Number | 3.65; 12.25; 11 |
| Strength Unit | g/500mL; g/500mL; g/500mL |
| Pharmaceutical Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |